Patent · US Active

Respiratory syncytial virus replication inhibitors

US7528149B2 · kind B2 · utility

13Cited by

5References

15Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Frans Eduard Janssens · Bonheiden, BE
Kathleen Petrus Marie-José Meersman · Wechelderzande, BE
François Maria Sommen · Wortel, BE
Koenraads Jozef Lodewijk Marcell Andries · Beerse, BE

Key dates

Filing date	Jan 22, 2007
Grant date	May 5, 2009
Priority date	—
Expiry date	Jan 22, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention concerns compounds of formula (I)prodrugs, addition salts, or stereochemically isomeric forms thereof for use as, inter alia, respiratory syncytial virus replication inhibitors; their preparation, compositions containing them and methods of their use in treating respiratory syncytial viral infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.